Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
-0.63%
)
US TECH 100
25,895.20
(
0.09%
)
Dow Jones
49,149.38
(
-0.60%
)
Brent Oil
94.35
(
-0.69%
)
Bitcoin
77,476.34
(
1.50%
)
News Focus
News Focus
Post# of 822356
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Investor082

Send PM Follow Ignore
Followers 4
Posts 5071
Boards Moderated 1
Alias Born 03/21/2024

Investor082

Re: kabunushi post# 795707

Friday, 10/31/2025 9:29:54 AM

Friday, October 31, 2025 9:29:54 AM

Post# of 822356
Without reimbursement approval, they wont hit more than $10-15M in annual revenue from DCVAX-L in the first year. So they wont even end up using capacity for 100 patients. Take that to the bank!

Specials program is a strong indicator as to how many patients are able to pay out of pocket for such a high cost therapy.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News